The decision to fulfill an order for synthetic nucleic acids hinges on whether the customer can be trusted to receive them. A consensus on customer screening...

Rapid advancements in AI have enabled significant progress in protein and nucleic acid design, but they also pose biosecurity challenges. We examine the vuln...

The Common Mechanism (Commec) is a free, open-source, globally-available tool for DNA synthesis screening, developed by IBBIS. Screen orders in compliance with global biosecurity standards, locally an...

Where Science Meets Security

TRIBUNE. Pendant que les Etats-Unis et le Royaume-Uni adoptent des politiques pour encadrer la synthèse d’ADN, l’Europe tergiverse. Un retard qui pourrait coûter cher à une bioéconomie pesant 728 mill...

A coalition of leading organisations from the synthetic biology, biotechnology, and health security communities is launching a joint position paper urging the European Commission to embed harmonised D...

Microsoft researchers found a biological zero-day vulnerability — and created a software patch.

The paper shows screening tools can be made resilient to AI protein designs and sets a precedent for responsible red-teaming of synthesis screening.